Afeyan Noubar's Form 4 filing
Codiak BioSciences, Inc. (CDAK) · filed Sep 16, 2022
- Accession no.
- 0000899243-22-031404
- Filed
- Sep 16, 2022, 7:30 PM ET
- Trade date
- Sep 15, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | 10% Owner |
| Flagship Ventures Fund V, L.P.CIK 0001627639 | 10% Owner |
| Flagship Ventures Fund V General Partner LLCCIK 0001724575 | 10% Owner |
| Flagship V VentureLabs Rx Fund, L.P.CIK 0001724939 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Common Stock | PPurchaseAcquired | +722,590 | – | – | 1,865,767 | Indirect | |
| Sep 15, 2022 | Common Stock | PPurchaseAcquired | +210,743 | – | – | 1,188,920 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Common Stock | PPurchaseAcquired | +722,590 | – | – | 722,590 | Indirect | |
| Sep 15, 2022 | Common Stock | PPurchaseAcquired | +210,743 | – | – | 210,743 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.